Multidrug Resistance Common in Hospitalized Adults With HIV in Malawi Multidrug Resistance Common in Hospitalized Adults With HIV in Malawi
HIV-1 multidrug resistance is common and is associated with increased mortality among adults hospitalized with HIV infection in Malawi, according to a new study.Reuters Health Information (Source: Medscape Hiv-Aids Headlines)
Source: Medscape Hiv-Aids Headlines - September 18, 2020 Category: Infectious Diseases Tags: HIV/AIDS News Source Type: news

Identifying Facilities at Risk of Receiving MDRO Patients Identifying Facilities at Risk of Receiving MDRO Patients
A novel new tool may help identify which healthcare facilities are at risk of receiving patients infected with multidrug-resistant organisms.Emerging Infectious Diseases (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 9, 2020 Category: Consumer Health News Tags: Infectious Diseases Journal Article Source Type: news

Notes from the Field: Multidrug-Resistant Tuberculosis Among Workers at Two Food Processing Facilities - Ohio, 2018-2019
This report describes an investigation of three cases of multidrug-resistant tuberculosis that occurred at two food processing facilities in Ohio. (Source: CDC Morbidity and Mortality Weekly Report)
Source: CDC Morbidity and Mortality Weekly Report - August 13, 2020 Category: American Health Tags: MMWR Morbidity & Mortality Weekly Report Multidrug-Resistant TB (MDR TB) Tuberculosis (TB) Source Type: news

Test accurately IDs people whose gonorrhea can be cured with simple oral antibiotic
A test designed by UCLA researchers can pinpoint which people with gonorrhea will respond successfully to the inexpensive oral antibiotic ciprofloxacin, which had previously been sidelined over concerns the bacterium that causes the infection was becoming resistant to it.In research published in the peer-reviewed journal Clinical Infectious Diseases,a UCLA-led team found thatof106 subjectsthe test identified as having a strain ofgonorrhea called wild-type gyrA serine, all were cured with a single dose of oral ciprofloxacin. Though the test has been available for three years, this is the first time it has been systematicall...
Source: UCLA Newsroom: Health Sciences - August 13, 2020 Category: Universities & Medical Training Source Type: news

New generation of drugs show early efficacy against drug-resistant TB
(Harvard Medical School) New drug regimen for multidrug-resistant tuberculosis shows early effectiveness in 85 percent of patients in a cohort including many with serious comorbidities. The results suggest a global need for expanded access to two recently developed medicines, bedaquiline and delamanid. Study cohort included many people who would have been excluded from trials because of comorbidities, severity of disease or extent of drug resistance. Findings highlight the importance of innovative regimens to improve outcomes for patients with multidrug-resistant tuberculosis. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 12, 2020 Category: International Medicine & Public Health Source Type: news

Africa: TB Alliance Announces European Commission Authorisation of New Treatment for Highly Drug-Resistant Tuberculosis
[TB Alliance] PRETORIA (3 August 2020)--Pretomanid, a novel compound developed by the non-profit organization TB Alliance, has been granted a conditional marketing authorisation by the European Commission (EC) for treating highly drug-resistant forms of pulmonary tuberculosis (TB).[i] The new drug was authorised as part of a three-drug, six month, all-oral regimen for the treatment of adults with extensively drug-resistant TB (XDR-TB) or multidrug-resistant TB (MDR-TB) who are treatment-intolerant or non-responsive (Source: AllAfrica News: Tuberculosis)
Source: AllAfrica News: Tuberculosis - August 4, 2020 Category: Infectious Diseases Source Type: news

Johnson & Johnson Reports 2020 Second-Quarter Results
New Brunswick, N.J. (July 16, 2020) – Johnson & Johnson (NYSE: JNJ) today announced results for second-quarter 2020. “Our second quarter results reflect the impact of COVID-19 and the enduring strength of our Pharmaceutical business, where we saw continued growth even in this environment,” said Alex Gorsky, Chairman and Chief Executive Officer. “Thanks to the tireless work of our colleagues around the world and our broad range of capabilities, we continue to successfully navigate the external landscape, and we remain focused on advancing the development of a vaccine to help address this pandemic...
Source: Johnson and Johnson - July 16, 2020 Category: Pharmaceuticals Source Type: news

Our Pets May Harbor Much More Than Coronavirus
While concern over SARS-CoV-2 in dogs and cats has captured attention, scientists have also been investigating whether pets can transmit multidrug-resistant bacteria to us. (Source: The Scientist)
Source: The Scientist - July 13, 2020 Category: Science Tags: Notebook Magazine Issue Source Type: news

Rukobia Approved for Patients With Multidrug-Resistant HIV
Title: Rukobia Approved for Patients With Multidrug-Resistant HIVCategory: Health NewsCreated: 7/7/2020 12:00:00 AMLast Editorial Review: 7/8/2020 12:00:00 AM (Source: MedicineNet HIV General)
Source: MedicineNet HIV General - July 8, 2020 Category: Infectious Diseases Source Type: news

Rukobia Approved for Patients With Multidrug-Resistant HIV
TUESDAY, July 7, 2020 -- A new type of antiretroviral medication, Rukobia (fostemsavir), has been approved for people with HIV who have not had success with other therapies, the U.S. Food and Drug Administration announced Thursday. Rukobia, 600 mg... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - July 7, 2020 Category: General Medicine Source Type: news

FDA OKs First-in-Class HIV Therapy for Patients With Few Options FDA OKs First-in-Class HIV Therapy for Patients With Few Options
Fostemsavir (Rukobia) is indicated for heavily treatment-experienced patients living with multidrug-resistant HIV infection.FDA Approvals (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - July 7, 2020 Category: Drugs & Pharmacology Tags: HIV/AIDS News Alert Source Type: news

Stop TB Partnership and Johnson & Johnson, with support from USAID and The Global Fund, Announce Price Reduction for SIRTURO ® (bedaquiline) for Treatment of Drug-Resistant Tuberculosis in Low- and Middle-Income Countries
GENEVA, SWITZERLAND, 6 JULY 2020 – The Stop TB Partnership and Johnson & Johnson – with support from the Global Fund to Fight AIDS, TB and Malaria, and the U.S. Agency for International Development (USAID) – today announced joint efforts to help enable low- and middle-income countries to rapidly scale up use of SIRTURO® (bedaquiline) 100mg tablets in support of new, recently-released World Health Organization (WHO) treatment guidelines. Effective immediately, Johnson & Johnson will make bedaquiline available to Stop TB Partnership’s Global Drug Facility (GDF) at a price of USD$340 per si...
Source: Johnson and Johnson - July 6, 2020 Category: Pharmaceuticals Tags: Innovation Source Type: news

A novel mechanism of mitochondrial dysfunctions-triggered the calcium signalling-dependent fungal multidrug resistance
Conference abstracts (Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - June 20, 2020 Category: Respiratory Medicine Authors: MeganB Source Type: news

Clinical outcomes of empirical high-dose meropenem in critically ill patients with sepsis and septic shock: A randomized controlled trial
Conclusion(s): Empirical therapy with the high-dose meropenem presented comparable clinical outcomes to the standard-dose meropenem in sepsis and septic shock patients. Besides, subgroup analysis manifested superior microbiological cure rate in sepsis or septic shock patients admitted from ED. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - June 4, 2020 Category: Consumer Health News Source Type: news

FDA Approves New Pediatric Formulation of Sirturo (bedaquiline) as Part of Combination Therapy to Treat Children with Pulmonary Multidrug-Resistant Tuberculosis
NEW BRUNSWICK, NJ, May 27, 2020— The Janssen Pharmaceutical Companies of Johnson& Johnson today announced that the U.S. Food and Drug Administration (FDA) has granted approval for a new pediatric formulation of Sirturo (bedaquiline).... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - May 28, 2020 Category: Drugs & Pharmacology Source Type: news

U.S. FDA Approves New Pediatric Formulation of SIRTURO ® (bedaquiline) as Part of Combination Therapy to Treat Children with Pulmonary Multidrug-Resistant Tuberculosis
NEW BRUNSWICK, NJ, May 27, 2020 — The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the U.S. Food and Drug Administration (FDA) has granted approval for a new pediatric formulation of SIRTURO® (bedaquiline). SIRTURO® is now indicated for use as part of combination therapy in the treatment of adult and pediatric patients (5 years and older and weighing at least 15 kg) with pulmonary multidrug-resistant tuberculosis (MDR‑TB). In the U.S., the medicine should be reserved for use when an effective treatment regimen cannot otherwise be provided. This indication received acceler...
Source: Johnson and Johnson - May 27, 2020 Category: Pharmaceuticals Tags: Innovation Source Type: news

FMT Helps Without Clearing Multidrug-Resistant Organisms FMT Helps Without Clearing Multidrug-Resistant Organisms
For seriously ill patients with multidrug-resistant organisms in their gastrointestinal tract, fecal microbiota transplant (FMT) might result in fewer and less severe infections, investigators report.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - May 20, 2020 Category: Consumer Health News Tags: Gastroenterology News Source Type: news

Antibiotic exposure can 'prime' single-resistant bacteria to become multidrug-resistant
(University of Washington) Researchers at the University of Washington and the University of Idaho report that, for a bacterial pathogen already resistant to an antibiotic, prolonged exposure to that antibiotic not only boosted its ability to retain its resistance gene, but also made the pathogen more readily pick up and maintain resistance to a second antibiotic and become a dangerous, multidrug-resistant strain. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 27, 2020 Category: International Medicine & Public Health Source Type: news

Study suggests pets are not a major source of transmission of drug-resistant microbes to their owners
(European Society of Clinical Microbiology and Infectious Diseases) New research due to be presented at this year's European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) has identified genetically identical multidrug-resistant bacteria in humans and their pets, suggesting human-animal transfer is possible in this context. However only a small number of cases were found, suggesting this is not a major source of antibiotic-resistant infections in humans. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 19, 2020 Category: International Medicine & Public Health Source Type: news

Study reveals raw-type dog foods as a major source of multidrug-resistant bacteria that could potentially colonize humans
(European Society of Clinical Microbiology and Infectious Diseases) New research due to be presented at this year's European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) reveals that raw-type dog foods contain high levels of multidrug-resistant bacteria, including those resistant to last-line antibiotics. The potential transfer of such bacteria between dogs and humans is an international public health risk. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 19, 2020 Category: International Medicine & Public Health Source Type: news

Cancer drug resistance study raises immune red flags
(Scripps Research Institute) Once a cancer patient's tumors develop resistance to chemotherapy, the prognosis can be poor. However, inhibiting a key gene involved in multidrug resistance, MDR1, has not improved outcomes. A new study offers a reason, revealing unintended downstream effects on immune system cells. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - April 17, 2020 Category: Biology Source Type: news

Suppressing Stomach Acid May Up Intestinal Growth of MDROs
THURSDAY, April 9, 2020 -- Stomach acid suppression medications increase the odds of intestinal colonization with multidrug-resistant microorganisms (MDROs), according to a review and meta-analysis recently published in JAMA Internal Medicine. Roel... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 9, 2020 Category: Pharmaceuticals Source Type: news

Some Multidrug-Resistant Bacterial Infections Down in U.S.
WEDNESDAY, April 8, 2020 -- From 2012 to 2017, there were decreases in the incidence of some multidrug-resistant (MDR) bacterial infections in hospitalized patients in the United States, according to a study published in the April 2 issue of the New... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 8, 2020 Category: Pharmaceuticals Source Type: news

EMA Panel Backs Pretomanid for Drug-Resistant TB EMA Panel Backs Pretomanid for Drug-Resistant TB
Pretomanid FGK, in combination with bedaquiline and linezolid, is for adults with extensively drug-resistant, treatment-intolerant, or nonresponsive multidrug-resistant tuberculosis.International Approvals (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - March 31, 2020 Category: Drugs & Pharmacology Tags: Infectious Diseases News Source Type: news

Fostemsavir Active in Multidrug-Resistant HIV-1 Infection
THURSDAY, March 26, 2020 -- Amongpatients with multidrug-resistant HIV-1 infection who have limited therapy options, reductions in HIV-1 RNA level were significantly greater in those who received fostemsavir compared with placebo during the first... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 26, 2020 Category: Pharmaceuticals Source Type: news

Treatment of Multidrug-Resistant Gram-Negative SSIs Treatment of Multidrug-Resistant Gram-Negative SSIs
SSIs caused by multidrug-resistant gram-negative bacteria can pose treatment challenges. Learn about the currently available therapeutic options as well as those under development.Current Opinion in Infectious Diseases (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 25, 2020 Category: Consumer Health News Tags: Infectious Diseases Journal Article Source Type: news

Developing a novel oral antibiotic to treat multidrug-resistant gonorrhea
(Penn State) Up to $2.86M has been awarded to a research team including Penn State scientists and the biopharmaceutical company Microbiotix to develop a new oral antibiotic to treat multidrug-resistant gonorrhea. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 19, 2020 Category: International Medicine & Public Health Source Type: news

New Weapon in Fight Against Multidrug-Resistant TB
Title: New Weapon in Fight Against Multidrug-Resistant TBCategory: Health NewsCreated: 3/4/2020 12:00:00 AMLast Editorial Review: 3/5/2020 12:00:00 AM (Source: MedicineNet Lungs General)
Source: MedicineNet Lungs General - March 5, 2020 Category: Respiratory Medicine Source Type: news

New Weapon in Fight Against Multidrug-Resistant TB
WEDNESDAY, March 4, 2020 -- While the world's focus is trained on the new coronavirus, a groundbreaking clinical trial finds researchers battling a tough-to-treat form of an " old " infectious disease, tuberculosis. TB is a bacterial infection that... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - March 4, 2020 Category: General Medicine Source Type: news

ACTG to present new HIV and TB research at CROI 2020
(University of California - Los Angeles Health Sciences) ACTG investigators will present data in oral presentations and themed discussions on the impact of chronic antiretroviral therapy (ART) on a novel metric of the HIV reservoir, predictors of multidrug resistant tuberculosis (MDR-TB) in resource-limited settings, findings from the first HIV cure trial that exclusively enrolled women, and interactions between contraceptives and TB drugs and the vaginal microbiome. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - March 3, 2020 Category: Infectious Diseases Source Type: news

Notes from the Field: Carbapenem-resistant Klebsiella pneumoniae with mcr-1 Gene Identified in a Hospitalized Patient - Wyoming, January 2019
In December of 2018, Wyoming identified the state's first case of carbapenem-resistant Enterobacteriaceae (CRE) containing mcr-1, which is a gene that can make bacteria resistant to colistin, a drug that can be the last resort for some multidrug-resistant infections like CRE. (Source: CDC Morbidity and Mortality Weekly Report)
Source: CDC Morbidity and Mortality Weekly Report - February 13, 2020 Category: American Health Tags: Antibiotic and Antimicrobial Resistance Carbapenem Resistant Enterobacteriaceae (CRE) MMWR Morbidity & Mortality Weekly Report Carbapenem Resistant Enterobacteriaceae CRE Source Type: news

Impact of Ibalizumab for People With Multidrug-Resistant HIV Impact of Ibalizumab for People With Multidrug-Resistant HIV
Is ibalizumab an effective and financially feasible therapeutic option for those with multidrug-resistant HIV?JAIDS: Journal of Acquired Immune Deficiency Syndromes (Source: Medscape Hiv-Aids Headlines)
Source: Medscape Hiv-Aids Headlines - January 30, 2020 Category: Infectious Diseases Tags: HIV/AIDS Journal Article Source Type: news

Can this newly developed compound help fight antibiotic-resistant superbugs?
(Natural News) People who believe that the next massive health threat would be the rise of multidrug-resistant bacteria or “superbugs” slightly missed their mark: the threat is no longer on the horizon; it’s already here, says a recent report by the Centers for Disease Control and Prevention. In a statement, Robert Redfield, director of the CDC, said that the... (Source: NaturalNews.com)
Source: NaturalNews.com - January 28, 2020 Category: Consumer Health News Source Type: news

Candida auris outbreak: Mortality, interventions and cost of sustaining control
Candida auris has recently emerged as a global cause of multidrug resistant fungal outbreaks. An outbreak occurred at a tertiary care center in London in 2016. Transmission characteristics, interventions, patient outcomes and cost of resources are described. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - January 16, 2020 Category: Consumer Health News Source Type: news

Taking one for the team: How bacteria self-destruct to fight viral infections
(University of California - San Diego) UC San Diego School of Medicine researchers have discovered how a new immune system works to protect bacteria from phages, viruses that infect bacteria -- new information that could be leveraged to improve treatment of multidrug-resistant bacterial infections by refining phage therapy. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - January 10, 2020 Category: Infectious Diseases Source Type: news

RCPCH demands urgent action on air quality
Air pollution single greatest environmental threat to public health in the UK, especially for children and deprived communities Related items fromOnMedica Pollution kills 1.7 million children, says WHO Should we have compulsory measles vaccination at school entry? Multidrug-resistant TB spreads less easily than ‘normal’ TB Fewer lung symptoms in children as air pollution levels drop Texting can improve flu jab uptake (Source: OnMedica Latest News)
Source: OnMedica Latest News - January 10, 2020 Category: UK Health Source Type: news

Can this newly developed compound help fight antibiotic-resistant superbugs?
(Natural News) People who believe that the next massive health threat would be the rise of multidrug-resistant bacteria or “superbugs” slightly missed their mark: the threat is no longer on the horizon; it’s already here, says a recent report by the Centers for Disease Control and Prevention. In a statement, Robert Redfield, director of the... (Source: NaturalNews.com)
Source: NaturalNews.com - January 9, 2020 Category: Consumer Health News Source Type: news

Antimicrobial prescribing: ceftolozane with tazobactam for treating hospital-acquired pneumonia, including ventilator-associated pneumonia
The manufacturer of ceftolozane with tazobactam anticipates that it will be used in line with good antimicrobial stewardship, on the advice of a microbiologist, to treat critically ill ventilated adults with HAP and VAP, who are deteriorating or not responding to initial antibiotic therapy, and who have confirmed or highly suspected Pseudomonas aeruginosa. Specialists involved in producing this evidence summary consider that ceftolozane with tazobactam provides a potentially useful alternative for treating some adults with HAP and VAP who have limited treatment options because they have infections suspected or proven to be...
Source: Current Awareness Service for Health (CASH) - December 19, 2019 Category: Consumer Health News Source Type: news

Drug-Susceptible and Multidrug-Resistant M. tuberculosis Drug-Susceptible and Multidrug-Resistant M. tuberculosis
This report describes an uncommon case of drug-susceptible and multidrug-resistant tuberculosis due to a mixed-strain infection.Emerging Infectious Diseases (Source: Medscape Hiv-Aids Headlines)
Source: Medscape Hiv-Aids Headlines - December 16, 2019 Category: Infectious Diseases Tags: Infectious Diseases Journal Article Source Type: news

From cancer medication to antibiotic
(Technical University of Munich (TUM)) Antibiotic-resistant bacteria are increasingly the source of deadly infections. A team of scientists from the Technical University of Munich (TUM) and the Helmholtz Center for Infection Research (HZI) in Braunschweig have now modified an approved cancer drug to develop an active agent against multidrug-resistant pathogens. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - December 16, 2019 Category: Infectious Diseases Source Type: news

Recommendations Developed for Multidrug-Resistant Tuberculosis
THURSDAY, Nov. 21, 2019 -- In a new clinical practice guideline, published online Nov. 15 in the American Journal of Respiratory and Critical Care Medicine, recommendations are presented for the treatment of multidrug-resistant tuberculosis... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 21, 2019 Category: Pharmaceuticals Source Type: news

Antibiotics and Adverse Events Antibiotics and Adverse Events
Properly implemented antibiotic stewardship programs can play an important role in reducing the incidence of multidrug-resistant infections and antibiotic-associated adverse events.Current Opinion in Infectious Diseases (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 21, 2019 Category: Consumer Health News Tags: Infectious Diseases Journal Article Source Type: news

Multidrug-Resistant Pathogens Common in MSM With Gastroenteritis Multidrug-Resistant Pathogens Common in MSM With Gastroenteritis
Men who have sex with men (MSM) have high rates of infectious gastroenteritis, and infections with multidrug-resistant pathogens are common, according to new findings.Reuters Health Information (Source: Medscape Hiv-Aids Headlines)
Source: Medscape Hiv-Aids Headlines - November 5, 2019 Category: Infectious Diseases Tags: Infectious Diseases News Source Type: news

AI Beats Out Clinicians in Triaging Postoperative Patients for ICU
How good is artificial intelligence in decision-making? Not bad according to findings from a pilot study that was recently presented at the American College of Surgeons Clinical Congress 2019. Findings from the study show AI in the form of a machine-learned algorithm correctly triaged the vast majority of postoperative patients to the intensive care unit in its first proof-of-concept application in a university hospital setting. As it stands now surgical teams typically rely on clinical judgment to decide which patients need postoperative intense care because there is no single set of fixed criteria to make the determinati...
Source: MDDI - October 30, 2019 Category: Medical Devices Authors: MDDI Staff Tags: Digital Health Source Type: news

Transmissibility and potential for disease progression of drug resistant Mycobacterium tuberculosis: prospective cohort study
This study (10,160 household contacts [HCs] of 3339 index patients) found HCs exposed to patients with multidrug resistant TB had 8% higher risk of infection by end of follow-up vs. HCs of patients with drug sensitive TB. Risk of TB disease did not differ among contacts in both groups. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - October 25, 2019 Category: Consumer Health News Source Type: news

Global Tuberculosis Report 2019
The Global Report includes trends in TB incidence and mortality, data on case detection and treatment results for TB, multidrug-resistant TB, TB/HIV, and TB prevention. The report also includes an overview of pipelines for new TB diagnostics, drugs and vaccines. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - October 22, 2019 Category: Consumer Health News Source Type: news

Tuberculosis Infections Declining, But Not Fast Enough Among Poor, Marginalised: UN Health Agency
A 25 year-old tuberculosis patient is treated at her home in Funafuti, the main island of Tuvalu in the South Pacific. Credit: UNDP Tuvalu/Aurélia Rusek.By External SourceUNITED NATIONS, Oct 17 2019 (IPS) A staggering 1.5 million people died from tuberculosis (TB) last year, the UN health agency said on Thursday, in an appeal for far greater funding and political support to eradicate the curable and preventable disease. Caused by the bacteria Mycobacterium tuberculosis, TB commonly causes persistent coughing, fatigue and weight loss. According to the World Health Organization (WHO) and its latest Global TB Report, a...
Source: IPS Inter Press Service - Health - October 17, 2019 Category: International Medicine & Public Health Authors: External Source Tags: Global Headlines Health Poverty & SDGs Source Type: news

Bacteria Are Likely Hiding In Your Household Washing Machine
(CNN) — When multidrug-resistant pathogens kept reappearing on the skin of premature babies in a German hospital’s neonatal intensive care unit, investigators were confused. Tests for contamination in the incubators, as well as among healthcare workers who came into contact with the preemies, were all coming up negative, according to a report on the case published Friday by the American Society for Microbiology. But tests showed the babies were continually being reinfected with Klebsiella oxytoca, a bacteria notorious for hospital-acquired infections such as pneumonia, urinary tract infection, soft tissue infec...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - September 27, 2019 Category: Consumer Health News Authors: Health – CBS Boston Tags: Health News Offbeat CNN Source Type: news

Risk Factors for MDROs Among Deceased Organ Donors Risk Factors for MDROs Among Deceased Organ Donors
What factors may help identify the deceased transplant donors at risk of carrying multidrug-resistant organisms?American Journal of Transplantation (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 12, 2019 Category: Consumer Health News Tags: Transplantation Journal Article Source Type: news